Acodyne raises €2.5M: autonomous cargo drones are crossing from commercial delivery into defence resupply, as $8B pours into military robotics.
NUS researchers built a self-training platform that strengthens lab-grown muscle tissue around the clock, powering OstraBot to a record 467 mm/min — the fastest skeletal muscle-driven biohybrid robot ever reported.
Apeiron Labs raised $9.5M to deploy swarms of low-cost autonomous underwater vehicles (AUVs). The compact cloud-connected drones dive 400m, sampling temperature and acoustics for defense and civilian customers.
EdgeCortix's SAKURA-II becomes the first edge AI chip to pass NASA heavy ion testing, earn a DIU Success Memorandum, and complete US Air Force flight validation — 60 TOPS at 8W for orbital and tactical edge inference.
The FDA needs patient data to approve drugs. Rare-disease patients have the least data. That contradiction is why synthetic data is now gaining regulatory traction — and changing the economics of orphan-drug development.
An AI copilot for robotic surgery completed its first live clinical demonstration in Ghent. The surgical robotics market reached $18.3B, with AI-enabled systems capturing 35% of new installations. At least four research groups now field working prototypes.
CRISPR and AI-driven gene-target discovery are converging with NASA and startup-built space agriculture systems, creating a new frontier at the intersection of biotech and deep-space food autonomy.
The FDA cleared the first AI software for hemorrhage triage in combat casualties — an Android app that stratifies bleeding risk in 10 minutes using only heart rate and blood pressure. Validated on 5,895 patients across 8 medical centers.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
